MLB: Rangers purchase contract of LHP Dallas Keuchel

Date:

Share post:


Left-hander Dallas Keuchel officially had his contract purchased by the Texas Rangers on Saturday and was set to make his debut in a start against the visiting Detroit Tigers.

On Friday, the Rangers opened a roster spot by placing left-hander Cole Ragans (calf) on the 15-day injured list.

Keuchel, a former American League Cy Young Award winner, was signed to a minor league deal by Texas in late July after he was released by the Arizona Diamondbacks.

The Rangers will be third big league team of the season for Keuchel, who is 2-7 with an 8.53 ERA in 12 starts. He went 2-5 with a 7.88 ERA in eight starts for the Chicago White Sox and 0-2 with a 9.64 ERA in four outings for the Diamondbacks.

Keuchel, 34, is 101-89 with a 3.92 ERA in 11 seasons with the Houston Astros (2012-18), Atlanta Braves (2019), White Sox (2020-22) and Diamondbacks (2022).

Keuchel, a two-time All-Star, won the Cy Young Award with the Astros in 2015 when he went 20-8 with a 2.48 ERA and two shutouts in 33 starts.

Keuchel went 1-0 with a 2.31 ERA in four starts at Triple-A Round Rock since joining the Texas organization.

Ragans, 24, is 0-2 with a 4.42 ERA in four starts during his rookie season.

–Field Level Media

spot_img

Related articles

MLB: A’s agree to one-year deal with RHP Jose Leclerc

Right-handed reliever Jose Leclerc made a free agent move within the American League West, agreeing to a one-year...

MLB: Japanese RHP Roki Sasaki says he’s signed with Dodgers

Japanese star right-hander Roki Sasaki announced on Instagram Friday that he will sign with the Los Angeles Dodgers. Sasaki,...

MLB: Mets roll dice on LHP A.J. Minter following hip surgery

The New York Mets agreed to terms with left-handed reliever A.J. Minter on Friday, landing one of Atlanta's...

MLB: Red Sox, All-Star OF Jarren Duran avoid arbitration

The Boston Red Sox announced a one-year deal with outfielder Jarren Duran on Friday, avoiding arbitration. Durran, 28, will...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.